1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine has been researched along with (1R,2S)-tranylcypromine hydrochloride in 2 studies
| Studies (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Trials (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Recent Studies (post-2010) (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Studies ((1R,2S)-tranylcypromine hydrochloride) | Trials ((1R,2S)-tranylcypromine hydrochloride) | Recent Studies (post-2010) ((1R,2S)-tranylcypromine hydrochloride) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 26 | 0 | 14 |
| Protein | Taxonomy | 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (IC50) | (1R,2S)-tranylcypromine hydrochloride (IC50) |
|---|---|---|---|
| trace amine-associated receptor 1 | Homo sapiens (human) | 2.097 | |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 2.1 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 4.5 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 2.8117 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
2 other study(ies) available for 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine and (1R,2S)-tranylcypromine hydrochloride
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |